Skip to main content
. 2021 Jun 29;92(Suppl 1):1–13. doi: 10.1007/s00104-021-01446-1

Table 3.

Outcomes and complications

Total First period Second period Third period
05/2018–10/2018 11/2018–04/2019 05/2019–10/2019
Patients (hernias) n = 225 (302) n = 60 (80) n = 87 (115) n = 78 (107)
Follow-up 6 weeks 211 (93.7%) 55 (91.6%) 80 (91.9%) 76 (97.4%)
Unplanned follow-up 9 (4.0%) 4 (6.7%) 3 (3.4%) 2 (2.6%)
Complications, n (%)
Urinary retention (CD 2) 8 (3.6%) 4 (4.6%) 1
Symptomatic seromaa 20 (6.6%) 9 (11.2%) 7 (6.0%) 4 (3.6%)
Conservative (CD 1) 12 (60.0%) 6 (66.7%) 5 (71.4%) 1 (25.0%)
Aspiration (CD 3a) 7 (35.0%) 2 (22.2%) 2 (28.6%) 3 (75.0%)
Operation (CD 3b) 1 (0.3%) 1 (1.2%)
Hematoma 10 (3.3%) 5 (6.2%) 3 (2.6%) 2 (1.8%)
Conservative (CD 1) 8 (80.0%) 5 2 1
Operation (CD 3b) 2 (20.0%) 1 1
Pulmonary embolism (CD 4) 1 (0.3%) 1
Deep vein thrombosis (CD 2) 1 (0.3%) 1
Epididymitis 7 (2.3%) 4 (5.0%) 3 (2.6%)
Antibiotics (CD 2) 7 4 3
Surgical site infection
Postoperative ileus
Recurrence

CD Clavien–Dindo classification of surgical complications

aThere is a significant trend to fewer seromas from the first to the last evaluation period (Chi-square test for trend, p = 0.043)